Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S. N. SHARANOVA"'
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 62-66 (2016)
There was a whole series of drugs that change the course of multiple sclerosis over the past 20 years. However, a single algorithm of patients of childbearing age has yet been developed. There are new drugs more efficiently, but at the same time with
Externí odkaz:
https://doaj.org/article/88ba2f0de98847dca463fb07543256b5
Autor:
E. V. POPOVA, A. N. BOYKO, M. V. DAVYDOVSKAYA, S. N. ZOLOTOVA, N. V. KHACHANOVA, S. N. SHARANOVA
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 57-61 (2016)
This review includes results of experimental and clinical studies of new oral drug teriflunomide for pathogenetic treatment of multiple sclerosis (MS). Given the mechanism of action, clinical data of the studies II and III phases of clinical efficacy
Externí odkaz:
https://doaj.org/article/21517898fbfa4ecabecd9572fe581508
Autor:
Ekaterina Popova, O E Konovalova, M. V. Krotenkova, S. N. Sharanova, V.V. Bryukhov, A. N. Boiko
Publikováno v:
Neuroscience and Behavioral Physiology. 48:676-679
We present two case reports of patients with diagnoses of Balo’s concentric sclerosis. The characteristics of the pathogenesis of this disease are considered in relation to the differential diagnosis against other types of multiple sclerosis and po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e5647597dc9b0fd43e9b9d12e2c13ff
https://doi.org/10.1007/s11055-018-0616-2
https://doi.org/10.1007/s11055-018-0616-2
Autor:
E. V. Lysogorskaya, M. S. Shustova, T. I. Yakushina, A. I. Sergeeva, Yu. V. Trinitatskii, T I Khaibullin, Roman Ivanov, D V Sazonov, O. E. Gur’yanova, M. N. Zakharova, A. N. Boiko, V. Yu. Lizhdvoi, Yu A Belova, L. A. Tsukurova, E. V. Granatov, F. A. Khabirov, Kotov Sv, Odinak Mm, N. Yu. Lashch, T. O. Simaniv, S. N. Sharanova, N. N. Babicheva, O. V. Trifonova, L. A. Aver’yanova
Publikováno v:
Neuroscience and Behavioral Physiology. 48:351-357
Objective. To seek evidence that Timexon (BCD-063, glatiramer acetate, Biocad, Russia) and Copaxone-Teva (Teva Pharmaceuticals Ltd., Israel) have similar efficacies in patients with remitting multiple sclerosis. Materials and methods. A multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36de5f335f6b3400f57d92ff4794d5bd
https://doi.org/10.1007/s11055-018-0570-z
https://doi.org/10.1007/s11055-018-0570-z
Autor:
F. A. Khabirov, O. V. Trifonova, T. O. Simaniv, Yu. V. Trinitatsky, L. A. Aver’yanova, A. I. Sergeeva, S. N. Sharanova, E. V. Granatov, T I Iakushina, N. N. Babicheva, D V Sazonov, L. A. Tsukurova, A N Boyko, N. Yu. Lashch, O. E. Gur’yanova, Kotov Sv, Roman Ivanov, Yu A Belova, Odinak Mm, E. V. Lysogorskaya, M. N. Zakharova, V Yu Lizhdvoy, M. S. Shustova, T I Khaibullin
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(10 Pt 2)
The article presents the results of international multicenter randomized double-blind, active and placebo-controlled, comparative phase 3 trial. The goal of the study was to demonstrate non-inferiority of BCD-063 (glatiramer acetate, manufactured by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d0ed41912bda932b4b44c4da99527c
https://pubmed.ncbi.nlm.nih.gov/28139613
https://pubmed.ncbi.nlm.nih.gov/28139613
Autor:
Demina Tl, A. N. Boiko, S. N. Sharanova, M. V. Davydovskaya, O. V. Boiko, Popova Nf, Khachanova Nv, Romashkin Av, Ovcharov Vv, Shchur Sg, Ekaterina Popova, Gusev Ei, N. Yu. Lashch
Publikováno v:
Neuroscience and Behavioral Physiology. 43:571-576
We summarize here 10 years of experience of using glatiramer acetate (Copaxone) in 74 patients with active remitting multiple sclerosis (MS). Significant decreases in the frequency of disease exacerbation over all 10 years were noted. Disease severit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5763790972c1b2a6e1530ed155b24129
https://doi.org/10.1007/s11055-013-9773-5
https://doi.org/10.1007/s11055-013-9773-5
Autor:
V. V. Bryukhov, O E Konovalova, S. N. Sharanova, A N Boyko, M. V. Krotenkova, Ekaterina Popova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 117:50
This article presents two clinical cases of patients diagnosed with Balo's concentric sclerosis. Distinctive features of the pathogenesis in the aspect of differential diagnosis from other forms of multiple sclerosis and possible treatment are discus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d716213a5324d8cbf0bc8b41d10820b0
https://doi.org/10.17116/jnevro20171172250-53
https://doi.org/10.17116/jnevro20171172250-53
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 114(2 Pt 2)
Multiple sclerosis is now regarded as a disease, which is based on genetic predisposition. Trigger mechanism are various exogenous factors. The Epstein-Barr virus is thought to be a trigger. This report provides information about possible mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a73b7936429c90dd07967f6d82fbdfe5
https://pubmed.ncbi.nlm.nih.gov/24662354
https://pubmed.ncbi.nlm.nih.gov/24662354
Autor:
A V, Stepanov, A A, Belogurov, A É, Mamedov, D, Melamed, I V, Smirnov, E S, Kuzina, D D, Genkin, A N, Boĭko, S N, Sharanova, A, Bacon, N A, Ponomarenko, A G, Gabibov
Publikováno v:
Bioorganicheskaia khimiia. 38(3)
Multiple Sclerosis (MS) is a serve autoimmune neurodegenerative disease. Development of innovative approaches of MS treatment is of a high priority in the modern immunology and pharmacy. In the present study we showed high therapeutic efficiency of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8604571115e9b075366067d26ffbfea8
https://pubmed.ncbi.nlm.nih.gov/22997702
https://pubmed.ncbi.nlm.nih.gov/22997702
Autor:
Iu A, Klimov, A N, Boĭko, N F, Popova, N Iu, Lashch, A V, Petrov, V V, Ovcharov, S N, Sharanova, O V, Riabukhina, E F, Krynkina, T T, Batysheva, A V, Romashkin
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(2 Pt 2)
Motor and coordination disorders are the most prominent clinical presentations of multiple sclerosis. Currently, good results were achieved in the pathogenetic treatment of the disease. However methods of treatment of motor and coordination disorders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5ffc0c4f902df2a42da813e561de55d
https://pubmed.ncbi.nlm.nih.gov/21916161
https://pubmed.ncbi.nlm.nih.gov/21916161